On November 22, 2022, the global finals and award ceremony of the 2022 Golden Panda Global Innovation and Entrepreneurship Competition were successfully concluded.

    The "New super blood-phobic nanofiber array dressing" project of Zhuhai Tiinfeng Biotechnology Co., LTD. (hereinafter referred to as Tiinfeng), a subsidiary of Zhuhai Tiinfeng Biotechnology Co., LTD. (hereinafter referred to as Tiinfeng Biology), successfully won the first place in the Shanghai competition area, successfully entered the global finals, and won the global Finals Excellence Award.

    According to the organizing committee of the competition, the 2022 Golden Panda Global Innovation and Entrepreneurship Competition aims to build a well-known brand of international double innovation competition, and aims to recruit technical experts and industrial leaders with core competitiveness for the world.

Eight regions are competing

    This year's Golden Panda Global Innovation and Entrepreneurship Competition has set up 5 domestic competition areas in Chengdu, Chongqing, Beijing, Shanghai and Shenzhen, set up 3 overseas competition areas in Asia Pacific (Seoul, South Korea), America (Silicon Valley, United States) and Europe (Aachen, Germany), and set up the cloud field competition for the first time, with a total of more than 2,200 entries. Around the new generation of information technology, cutting-edge biomedics and future technology three fields of project competition, and by the People's Daily, Sohu, NetEase full coverage.

    With the help of 57 ambassadors from eight regions around the world, more than 350 outstanding innovative projects participated in the online and offline competition after the preliminary screening of the competition organizing committee. In the cutting-edge biomedical track that Tiinfeng Biology participates in, there are many other excellent projects such as targeted complement innovative drugs and implantable eye muscle nerve stimulators.

    The preliminary and global finals of the Golden Panda Global Innovation and Entrepreneurship Competition were delivered by Mr. Xiong Yongchao, Chief Executive Officer of Titanran Technology.

Four core technologies open up a new technological revolution

    Mr. Xiong Yongchao said that with the sharp increase in demand for people's living standards, high-end dressings will become the mainstream of the dressing market. Compared with traditional dressings, the performance of the "new ultra-blood-phobic nanofiber array dressings" far exceeds the industry standard.

The "new super blood phobic nanofiber array dressing" project has been launched since the end of 2020, with a total investment of 20 million yuan. After tens of thousands of animal experiments, it has now entered the clinical trial stage, and its four core technologies can be realized:

Rapid blood clotting: the blood loss rate was reduced by 98.5%, and the survival time of mice was extended by about 90%.

Super antibacterial: Staphylococcus aureus and Escherichia coli bactericidal rate 99.999%, antibacterial performance increased 1000 times;

Easy to peel off: the maximum peeling force (pain) is reduced by 90 times;

Super fast healing: Healing time can be reduced by 125 times.

The emergence of "new super-blood-phobic nanofiber array dressings" can effectively reduce the pain of dressing changes for patients and realize medical comfort and humanization. Its four core technologies have opened a technological revolution after 3M medical dressings in the United States.

    In addition, in August 2022, Mr. Zhang Hailong, general manager and R&D director of Tiantian Technology, under the guidance of Professor Liu Libin, R&D consultant of the company, and teacher Zhang Jinxia, entrepreneurship mentor, participated in the 8th Shandong Province "Internet + Innovation and Entrepreneurship Competition" with the project "New Choice for Wound Healing - New super blood Thinning nanofiber array dressing". Stood out among more than 300,000 projects and won the gold medal in the competition.

    The index is several times higher than that of its competitors, making the "new super blood phobic nanofiber array dressing" very competitive in the bidding, and Tiifeng Biology, as its research and development company, has reached strategic cooperation with a number of leading enterprises, and the industry has great potential.